PFAM Search:   
       by Pfam accession/ID, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  

Full view: branches of nodes matching the query are shown completely (Compact view)

(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Clan: Peptidase_AA (368)
(-)
Family: Asp (155)
(-)
Blattella germanica (German cockroach) (Blatta germanica) (2)
2NR6B:13-325; B:13-325CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
3LIZA:13-325CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
(-)
Candida albicans (Yeast) (3)
2QZWB:13-330; B:13-330SECRETED ASPARTIC PROTEINASE (SAP) 1 FROM CANDIDA ALBICANS
1ZAPA:13-330SECRETED ASPARTIC PROTEASE FROM C. ALBICANS
2QZXB:13-330; B:13-330SECRETED ASPARTIC PROTEINASE (SAP) 5 FROM CANDIDA ALBICANS
(-)
Cryphonectria parasitica (Chesnut blight fungus) (Endothia parasitica) (6)
1OD1A:16-330ENDOTHIAPEPSIN PD135,040 COMPLEX
1OEWA:16-329ATOMIC RESOLUTION STRUCTURE OF NATIVE ENDOTHIAPEPSIN
1OEXA:16-329ATOMIC RESOLUTION STRUCTURE OF ENDOTHIAPEPSIN IN COMPLEX WITH A HYDROXYETHYLENE TRANSITION STATE ANALOGUE INHIBITOR H261
2JJIA:16-330ENDOTHIAPEPSIN IN COMPLEX WITH A GEM-DIOL INHIBITOR.
2V00A:16-330X-RAY CRYSTAL STRUCTURE OF ENDOTHIAPEPSIN COMPLEXED WITH COMPOUND 1
3LZYA:16-330CRYSTAL STRUCTURE OF ENDOTHIAPESIN IN COMPLEX WITH XENON
(-)
Homo sapiens (Human) (116)
1M4HB:13-357; B:13-357CRYSTAL STRUCTURE OF BETA-SECRETASE COMPLEXED WITH INHIBITOR OM00-3
1SGZD:13-357; D:13-357; D:13-357; D:13-357CRYSTAL STRUCTURE OF UNBOUND BETA-SECRETASE CATALYTIC DOMAIN.
1TQFA:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
1W50A:13-357APO STRUCTURE OF BACE (BETA SECRETASE)
1W51A:13-357BACE (BETA SECRETASE) IN COMPLEX WITH A NANOMOLAR NON-PEPTIDIC INHIBITOR
1XN2D:13-357; D:13-357; D:13-357; D:13-357NEW SUBSTRATE BINDING POCKETS FOR BETA-SECRETASE.
1XN3D:13-357; D:13-357; D:13-357; D:13-357CRYSTAL STRUCTURE OF BETA-SECRETASE BOUND TO A LONG INHIBITOR WITH ADDITIONAL UPSTREAM RESIDUES.
1XS7D:13-357CRYSTAL STRUCTURE OF A CYCLOAMIDE-URETHANE-DERIVED NOVEL INHIBITOR BOUND TO HUMAN BRAIN MEMAPSIN 2 (BETA-SECRETASE).
1YM4C:13-357; C:13-357; C:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH NVP-AMK640
2NTRA:13-357CRYSTAL STRUCTURE OF HUMAN BACE-1 BOUND TO INHIBITOR
2OAHA:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2OF0A:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 5
2OHKA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 1-AMINO-ISOQUINOLINE
2OHMA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH N~3~-BENZYLPYRIDINE-2,3-DIAMINE
2OHNA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH 4-(4-FLUOROBENZYL)PIPERIDINE
2OHPA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 3
2OHQA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 4
2OHRA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6A
2OHSA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 6B
2OHTA:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 7
2P4JD:13-357; D:13-357; D:13-357; D:13-357CRYSTAL STRUCTURE OF BETA-SECRETASE BOND TO AN INHIBITOR WITH ISOPHTHALAMIDE DERIVATIVES AT P2-P3
2P83C:13-357; C:13-357; C:13-357POTENT AND SELECTIVE ISOPHTHALAMIDE S2 HYDROXYETHYLAMINE INHIBITOR OF BACE1
2PH6A:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2PH8A:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH INHIBITOR
2Q11C:13-357; C:13-357; C:13-357STRUCTURE OF BACE COMPLEXED TO COMPOUND 1
2Q15A:13-357STRUCTURE OF BACE COMPLEXED TO COMPOUND 3A
2QK5B:74-418; B:74-418STRUCTURE OF BACE1 BOUND TO SCH626485
2QMDB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH722924
2QMFB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH735310
2QMGB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH745966
2QP8B:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH734723
2QU2A:75-419BACE1 WITH COMPOUND 1
2QU3A:75-419BACE1 WITH COMPOUND 2
2QZKA:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE COMPLEXED WITH I21
2VA5A:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 8C
2VA6A:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 24
2VA7A:13-357X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMPOUND 27
2VIEA:74-418HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-1-BENZYL-2-HYDROXY-3-((1,1,5-TRIMETHYLHEXYL)AMINO)PROPYL)-3-(ETHYLAMINO)-5-(2-OXOPYRROLIDIN-1-YL)BENZAMIDE
2VIJA:74-418HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1, 2-THIAZIN-2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL)-3-(1,2,3,4-TETRAHYDRO-1-NAPHTHALENYLAMINO) PROPYL)BENZAMIDE
2VIYA:74-418HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(PENTYLSULFONYL)BENZAMIDE
2VIZA:74-418HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(2-OXO-1-PYRROLIDINYL)-5-(PROPYLOXY) BENZAMIDE
2VJ6A:74-418HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2VKMD:13-357; D:13-357; D:13-357; D:13-357CRYSTAL STRUCTURE OF GRL-8234 BOUND TO BACE (BETA-SECRETASE)
2VNMA:74-418HUMAN BACE-1 IN COMPLEX WITH 3-(1,1-DIOXIDOTETRAHYDRO-2H-1, 2-THIAZIN-2-YL)-5-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-1-( PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)BENZAMIDE
2VNNA:74-418HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)-1-METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2-DIOXIDE
2WF0A:74-418HUMAN BACE-1 IN COMPLEX WITH 4-ETHYL-N-((1S,2R)-2-HYDROXY-1-(PHENYLMETHYL)-3-(((3-(TRIFLUOROMETHYL)PHENYL)METHYL)AMINO) PROPYL)-8-(2-OXO-1-PYRROLIDINYL)-6-QUINOLINECARBOXAMIDE
2WF1A:74-418HUMAN BACE-1 IN COMPLEX WITH 7-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL(METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-1-METHYL-3,4-DIHYDRO-1H-(1,2,5)THIADIAZEPINO(3,4,5-HI)INDOLE-9-CARBOXAMIDE 2,2-DIOXIDE
2WF2A:74-418HUMAN BACE-1 IN COMPLEX WITH 8-ETHYL-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL) PROPYL)-1-METHYL-3,4,7,8-TETRAHYDRO-1H,6H-(1,2,5) THIADIAZEPINO(5,4,3-DE)QUINOXALINE-10-CARBOXAMIDE 2,2-DIOXIDE
2WF3A:74-418HUMAN BACE-1 IN COMPLEX WITH 6-(ETHYLAMINO)-N-((1S,2R)-2-HYDROXY-3-(((3-(METHYLOXY)PHENYL)METHYL)AMINO)-1-(PHENYLMETHYL)PROPYL)-1-METHYL-1, 3,4,5-TETRAHYDRO-2,1-BENZOTHIAZEPINE-8-CARBOXAMIDE 2,2-DIOXIDE
2WF4A:74-418HUMAN BACE-1 IN COMPLEX WITH 6-ETHYL-1-METHYL-N-((1S)-2-OXO-1-(PHENYLMETHYL)-3-(TETRAHYDRO-2H-PYRAN-4-YLAMINO)PROPYL)-1,3,4,6-TETRAHYDRO(1,2)THIAZEPINO(5,4,3-CD)INDOLE-8-CARBOXAMIDE 2,2-DIOXIDE
2WJOA:13-357HUMAN BACE (BETA SECRETASE) IN COMPLEX WITH CYCLOHEXANECARBOXYLIC ACID (2-(2-AM INO-6-PHENOXY-4H-QUINAZOLIN-3-YL)-2-CYCLOHEXYL-ETHYL)-AMIDE
2XFIA:74-418HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-((METHYLSULFONYL)(PHENYL)AMINO) BENZAMIDE
2XFJA:74-418HUMAN BACE-1 IN COMPLEX WITH N-((1S,2R)-3-(((1S)-2-( CYCLOHEXYLAMINO)-1-METHYL-2-OXOETHYL)AMINO)-2-HYDROXY-1-( PHENYLMETHYL)PROPYL)-3-(ETHYLAMINO)-5-(2-OXO-1-PYRROLIDINYL)BENZAMIDE
2ZDZA:75-419X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 3.B.10
2ZE1A:75-419X-RAY STRUCTURE OF BACE-1 IN COMPLEX WITH COMPOUND 6G
2ZHRB:13-357; B:13-357CRYSTAL STRUCTURE OF BACE1 IN COMPLEX WITH OM99-2 AT PH 5.0
2ZHSA:13-357CRYSTAL STRUCTURE OF BACE1 AT PH 4.0
2ZHTA:13-357CRYSTAL STRUCTURE OF BACE1 AT PH 4.5
2ZHUA:13-357CRYSTAL STRUCTURE OF BACE1 AT PH 5.0
2ZHVA:13-357CRYSTAL STRUCTURE OF BACE1 AT PH 7.0
2ZJHA:13-357CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-(1-BENZYL-PIPERIDIN-4-YL)-4-MERCAPTO-BUTYRAMIDE
2ZJIA:13-357CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(2,6-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE
2ZJJA:13-357CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH 4-(4-FLUORO-BENZYL)-PIPERAZINE-2-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
2ZJLA:13-357CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-BROMO-2,3-DIMETHOXY-BENZYL)-PIPERIDIN-4-YL]-4-MERCAPTO-BUTYRAMIDE
2ZJMA:13-357CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(4-SULFAMOYL-PHENOXY)-ACETAMIDE
2ZJNA:13-357CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(2-METHYL-4-SULFAMOYL-PHENOXY)-ACETAMIDE
3K5CC:13-357; C:13-357; C:13-357HUMAN BACE-1 COMPLEX WITH NB-216
3K5DC:13-357; C:13-357; C:13-357CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH AHM178
3K5FC:13-357; C:13-357; C:13-357HUMAN BACE-1 COMPLEX WITH AYH011
3K5GC:13-357; C:13-357; C:13-357HUMAN BACE-1 COMPLEX WITH BJC060
3KMXB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH346572
3KMYB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH12472
3KN0B:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH708236
3KYRC:13-357; C:13-357; C:13-357BACE-1 IN COMPLEX WITH A NORSTATINE TYPE INHIBITOR
3L38A:75-419BACE1 IN COMPLEX WITH THE AMINOPYRIDINE COMPOUND 44
3L58B:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH589432
3L59B:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH710413
3L5BB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH713601
3L5CB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH723871
3L5DB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH723873
3L5EB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH736062
3L5FB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH736201
3LHGA:75-419BACE1 IN COMPLEX WITH THE AMINOHYDANTOIN COMPOUND 4G
3LPIB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH745132
3LPJB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH743641
3LPKB:74-418; B:74-418STRUCTURE OF BACE BOUND TO SCH747123
3MSJC:13-357; C:13-357; C:13-357STRUCTURE OF BACE (BETA SECRETASE) IN COMPLEX WITH INHIBITOR
3MSKA:13-357FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS
3MSLA:13-357FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS
3N4LC:19-363; C:19-363; C:19-363BACE-1 IN COMPLEX WITH ELN380842
3NSHC:19-363; C:19-363; C:19-363BACE-1 IN COMPLEX WITH ELN475957
3OHFB:61-405; B:61-405CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-WT) COMPLEX WITH BMS-655295 AKA N~3~-((1S,2R)-1- BENZYL-2-HYDROXY-3-((3-METHOXYBENZYL)AMINO)PROPYL)-N~1~, N~1~-DIBUTYL-1H-INDOLE-1,3-DICARBOXAMIDE
3OHHB:61-405; B:61-405CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 (BACE-WT) COMPLEX WITH BMS-681889 AKA N~1~-BUTYL-5-CYANO- N~3~-((1S,2R)-1-(3,5-DIFLUOROBENZYL)-2-HYDROXY-3-((3- METHOXYBENZYL)AMINO)PROPYL)-N~1~-METHYL-1H-INDOLE-1,3- DICARBOXAMIDE
3PI5C:13-357; C:13-357; C:13-357CRYSTAL STRUCTURE OF HUMAN BETA SECRETASE IN COMPLEX WITH BFG356
3QBHC:13-357; C:13-357; C:13-357STRUCTURE BASED DESIGN, SYNTHESIS AND SAR OF CYCLIC HYDROXYETHYLAMINE (HEA) BACE-1 INHIBITORS
3R1GB:74-418STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3S2OA:13-357FRAGMENT BASED DISCOVERY AND OPTIMISATION OF BACE-1 INHIBITORS
1LYAD:106-345; D:106-345; D:106-345; D:106-345CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
1LYBD:106-345; D:106-345; D:106-345; D:106-345CRYSTAL STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN D: IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
1LYWH:106-345; H:106-345; H:106-345; H:106-345; H:106-345; H:106-345; H:106-345; H:106-345CATHEPSIN D AT PH 7.5
1TZSA:24-341CRYSTAL STRUCTURE OF AN ACTIVATION INTERMEDIATE OF CATHEPSIN E
2RENA:19-339STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION
2V0ZO:13-325; O:13-325CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 10 (ALISKIREN)
2V10O:19-339; O:19-339CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 9
2V11O:19-339; O:19-339CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 6
2V12O:19-339; O:19-339CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 8
2V13A:19-339CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 7
2V16O:13-325; O:13-325CRYSTAL STRUCTURE OF RENIN WITH INHIBITOR 3
2X0BG:14-332; G:14-332; G:14-332; G:14-332CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
3O9LD:171-339; D:171-339; D:171-339; D:171-339DESIGN AND OPTIMISATION OF NEW PIPERIDINES AS RENIN INHIBITORS
3OADD:171-339; D:171-339; D:171-339; D:171-339DESIGN AND OPTIMIZATION OF NEW PIPERIDINES AS RENIN INHIBITORS
3OAGD:171-339; D:171-339; D:171-339; D:171-339DESIGN AND OPTIMIZATION OF NEW PIPERIDINES AS RENIN INHIBITORS
3OOTB:13-325; B:13-325CRYSTAL STRUCTURE ANALYSIS OF RENIN-INDOLE-PIPERAZIN INHIBITOR COMPLEXES
3OQFB:13-325; B:13-325CRYSTAL STRUCTURE ANALYSIS OF RENIN-INDOLE-PIPERAZINE INHIBITOR COMPLEXES
3OQKB:13-325; B:13-325CRYSTAL STRUCTURE ANALYSIS OF RENIN-INDOLE-PIPERAZIN INHIBITOR COMPLEXES
3OWNB:16-336; B:16-336POTENT MACROCYCLIC RENIN INHIBITORS
(-)
Hordeum vulgare (Barley) (1)
1QDMC:17-337; C:17-337; C:17-337CRYSTAL STRUCTURE OF PROPHYTEPSIN, A ZYMOGEN OF A BARLEY VACUOLAR ASPARTIC PROTEINASE.
(-)
Irpex lacteus (Milk-white toothed polypore) (Polyporus tulipiferae) (1)
1WKRA:13-332CRYSTAL STRUCTURE OF ASPARTIC PROTEINASE FROM IRPEX LACTEUS
(-)
Mus musculus (Mouse) (1)
1SMRG:13-325; G:13-325; G:13-325; G:13-325THE 3-D STRUCTURE OF MOUSE SUBMAXILLARY RENIN COMPLEXED WITH A DECAPEPTIDE INHIBITOR CH-66 BASED ON THE 4-16 FRAGMENT OF RAT ANGIOTENSINOGEN
(-)
Plasmodium falciparum (15)
3QRVB:13-325; B:13-325CRYSTAL STRUCTURE OF PLASMEPSIN I (PMI) FROM PLASMODIUM FALCIPARUM
3QS1D:13-325; D:13-325; D:13-325; D:13-325CRYSTAL STRUCTURE OF KNI-10006 COMPLEX OF PLASMEPSIN I (PMI) FROM PLASMODIUM FALCIPARUM
1LEEA:15-325CRYSTAL STRUCTURE OF PLASMEPSIN FROM P. FALCIPARUM IN COMPLEX WITH INHIBITOR RS367
1LF2A:15-325CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR RS370
1LF3A:15-325CRYSTAL STRUCTURE OF PLASMEPSIN II FROM P FALCIPARUM IN COMPLEX WITH INHIBITOR EH58
1LF4A:15-325STRUCTURE OF PLASMEPSIN II
1M43B:15-325; B:15-325CRYSTAL STRUCTURE OF PMII IN COMPLEX WITH PEPSTATIN A TO 2.4 A
1ME6B:15-325; B:15-325CRYSTAL STRUCTURE OF PLASMEPSIN II, AN ASPARTYL PROTEASE FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH A STATINE-BASED INHIBITOR
1PFZD:15-325; D:15-325; D:15-325; D:15-325PROPLASMEPSIN II FROM PLASMODIUM FALCIPARUM
1SMEB:15-325; B:15-325PLASMEPSIN II, A HEMOGLOBIN-DEGRADING ENZYME FROM PLASMODIUM FALCIPARUM, IN COMPLEX WITH PEPSTATIN A
1W6HB:15-325; B:15-325NOVEL PLASMEPSIN II-INHIBITOR COMPLEX
1W6IC:15-325; C:15-325PLASMEPSIN II-PEPSTATIN A COMPLEX
1XDHB:15-325; B:15-325STRUCTURE OF PLASMEPSIN II IN COMPLEX WITH PEPSTATIN A
1XE6B:15-325; B:15-325STRUCTURE OF PLASMEPSIN II IN COMPLEX OF AN PEPSTATIN ANALOGUE
2R9BB:15-325; B:15-325STRUCTURAL ANALYSIS OF PLASMEPSIN 2 FROM PLASMODIUM FALCIPARUM COMPLEXED WITH A PEPTIDE-BASED INHIBITOR
(-)
Plasmodium vivax (1)
1MIQB:15-325; B:15-325CRYSTAL STRUCTURE OF PROPLASMEPSIN FROM THE HUMAN MALARIAL PATHOGEN PLASMODIUM VIVAX
(-)
Rhizomucor pusillus (1)
1MPPA:13-325X-RAY ANALYSES OF ASPARTIC PROTEINASES. V. STRUCTURE AND REFINEMENT AT 2.0 ANGSTROMS RESOLUTION OF THE ASPARTIC PROTEINASE FROM MUCOR PUSILLUS
(-)
Rhizopus chinensis (Bread mold) (3)
1UH7A:16-323CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 4.6
1UH8A:16-323CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 8.0
1UH9A:16-323CRYSTAL STRUCTURE OF RHIZOPUSPEPSIN AT PH 7.0
(-)
Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Bakers yeast) (1)
2JXRA:13-325STRUCTURE OF YEAST PROTEINASE A
(-)
Solanum tuberosum (Potato) (1)
3RFIA:1-103CRYSTAL STRUCTURE OF THE SAPOSIN-LIKE DOMAIN OF PLANT ASPARTIC PROTEASE FROM SOLANUM TUBEROSUM
(-)
Sus scrofa (Pig) (3)
1PSAB:13-325; B:13-325STRUCTURE OF A PEPSIN(SLASH)RENIN INHIBITOR COMPLEX REVEALS A NOVEL CRYSTAL PACKING INDUCED BY MINOR CHEMICAL ALTERATIONS IN THE INHIBITOR
1YX9A:13-326EFFECT OF DIMETHYL SULPHOXIDE ON THE CRYSTAL STRUCTURE OF PORCINE PEPSIN
3PEPA:13-325REVISED 2.3 ANGSTROMS STRUCTURE OF PORCINE PEPSIN. EVIDENCE FOR A FLEXIBLE SUBDOMAIN